Alendronate News
Patients on bone-building drugs worry about 'jaw death'
As national medical organizations investigate bone-building drugs to examine a rare but devastating side effect, local doctors say they are watching but not changing their prescribing practices.
Drugs company Merck doubles second-quarter net income
The company's earnings exceeded analysts' estimates, Merck raised its 2006 forecast for a second time. Net income jumped to $1.5 billion, or 69 cents a share, from $720.6 million, or 33 cents, a year earlier, when profit was...
Monthly tablets help women persist longer with osteoporosis drugs
Women who took an osteoporosis drug once a month and received extra telephone support from trained nurses showed 47% greater persistence with their drug treatment than those who took a weekly tablet, according to the results of a...
New osteoporosis medication not cost-effective compared with older, cheaper drug, stanford study finds
Researchers at the Stanford University School of Medicine have found that the first such drug now available, called teriparatide (brand name Forteo), is not cost-effective compared with the most commonly prescribed osteoporosis...
Preventive measures can help ward off osteoporosis
Data revealed at the 2006 World Congress on Osteoporosis revealed that osteoporosis … or "brittle bone disease'' as it was once more commonly referred … now affects approximately 44 million men and women older than 50....